Status:
NOT_YET_RECRUITING
FAB Block vs. Placebo for Hip Arthroplasty Patients
Lead Sponsor:
Women's College Hospital
Conditions:
Hip Arthroplasty
Anesthesia, Regional
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
Hip arthroplasty surgery can be associated with significant pain. A regional anesthesia technique, the femoral articular branch block (FAB), has recently been proposed to collectively block terminal f...
Detailed Description
Hip arthroplasty procedure is frequently associated with severe post-operative pain despite the practice of injecting the hip joint with local anesthetics at the end of the procedure and the use of in...
Eligibility Criteria
Inclusion
- ASA I-III patients
- Ages 18-60yrs
- BMI ≤ 35 kg/m2
Exclusion
- Preexisting neurological deficits or peripheral neuropathy in the distribution of femoral, obturator, or lateral cutaneous nerves
- Local infection
- Contra-indication to regional anesthesia e.g. bleeding diathesis, coagulopathy
- Chronic pain disorders
- History of use of over 30mg oxycodone or equivalent per day
- Contraindication to a component of multi-modal analgesia
- Allergy to local anesthetics
- History of significant psychiatric conditions that may affect patient assessment
- Pregnancy
- Inability to provide informed consent
- Patient refusal of FAB
- Revision arthroscopy surgeries
Key Trial Info
Start Date :
December 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
95 Patients enrolled
Trial Details
Trial ID
NCT04301687
Start Date
December 1 2025
End Date
December 1 2026
Last Update
March 27 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.